α-Enolase, a Multifunctional Protein: Its Role on Pathophysiological Situations À Díaz-Ramos, A Roig-Borrellas, A García-Melero, R López-Alemany BioMed Research International 2012, 2012 | 435 | 2012 |
Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α‐Enolase R López‐Alemany, C Longstaff, S Hawley, M Mirshahi, P Fábregas, ... American journal of hematology 72 (4), 234-242, 2003 | 150 | 2003 |
Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo M Suelves, R López-Alemany, F Lluıs, G Aniorte, E Serrano, M Parra, ... Blood, The Journal of the American Society of Hematology 99 (8), 2835-2844, 2002 | 128 | 2002 |
Plasminogen activator inhibitor type‐1 inhibits insulin signaling by competing with αvβ3 integrin for vitronectin binding R López‐Alemany, JM Redondo, Y Nagamine, P Muñoz‐Cánoves European Journal of Biochemistry 270 (5), 814-821, 2003 | 95 | 2003 |
uPA deficiency exacerbates muscular dystrophy in MDX mice M Suelves, B Vidal, AL Serrano, M Tjwa, J Roma, R López-Alemany, ... The Journal of cell biology 178 (6), 1039-1051, 2007 | 91 | 2007 |
Identification of an epitope of α-enolase (a candidate plasminogen receptor) by phage display B Arza, J Félez, R Lopez-Alemany, LA Miles, P Munñoz-Cánoves Thrombosis and haemostasis 78 (09), 1097-1103, 1997 | 69 | 1997 |
Purification of the plasmin receptor from human carcinoma cells and comparison to α-enolase R Lopez-Alemany, P Correc, L Camoin, P Burtin Thrombosis research 75 (4), 371-381, 1994 | 67 | 1994 |
Plasmin generation dependent on α-enolase-type plasminogen receptor is required for myogenesis R López-Alemany, M Suelves, P Muñoz-Cánoves Thrombosis and haemostasis 90 (10), 724-733, 2003 | 59 | 2003 |
Alpha-enolase plasminogen receptor in myogenesis R Lopez-Alemany, M Suelves, A Diaz-Ramos, B Vidal, P Munoz-Canoves Front Biosci 10 (1), 30-36, 2005 | 54 | 2005 |
The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) M Suelves, B Vidal, V Ruiz, B Baeza-Raja, A Diaz-Ramos, I Cuartas, ... Front Biosci 10, 2978-2985, 2005 | 51 | 2005 |
EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma S Garcia‐Monclús, R López‐Alemany, O Almacellas‐Rabaiget, ... International journal of cancer 143 (5), 1188-1201, 2018 | 48 | 2018 |
Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway L Lagares-Tena, S García-Monclús, R López-Alemany, ... Oncotarget 7 (35), 56889, 2016 | 47 | 2016 |
Plasmin-mediated release of the guidance molecule F-spondin from the extracellular matrix V Tzarfaty-Majar, R López-Alemany, Y Feinstein, L Gombau, ... Journal of Biological Chemistry 276 (30), 28233-28241, 2001 | 43 | 2001 |
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1 J Huertas-Martínez, F Court, S Rello-Varona, D Herrero-Martin, ... Cancer letters 386, 196-207, 2017 | 30 | 2017 |
“(Not) all (dead) things share the same breath”: identification of cell death mechanisms in anticancer therapy S Rello-Varona, D Herrero-Martín, R López-Alemany, C Munoz-Pinedo, ... Cancer Research 75 (6), 913-917, 2015 | 26 | 2015 |
Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth J Huertas-Martínez, S Rello-Varona, D Herrero-Martín, I Barrau, ... Oncotarget 5 (20), 9744, 2014 | 23 | 2014 |
Requirement of plasminogen binding to its cell-surface receptor α-enolase for efficient regeneration of normal and dystrophic skeletal muscle À Díaz-Ramos, A Roig-Borrellas, A García-Melero, A Llorens, ... PLoS One 7 (12), e50477, 2012 | 21 | 2012 |
LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity O Almacellas-Rabaiget, P Monaco, J Huertas-Martinez, S García-Monclús, ... Cancer Letters 474, 1-14, 2020 | 20 | 2020 |
Comparative localization of receptors for plasmin and for urokinase on MCF7 cells S Zhang, M Laurent, R Lopez-Alemany, A Mazar, J Henkin, E Ronne, ... Experimental cell research 207 (2), 290-299, 1993 | 17 | 1993 |
The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy S Rello-Varona, D Herrero-Martín, L Lagares-Tena, R López-Alemany, ... Frontiers in Oncology 5, 82, 2015 | 16 | 2015 |